MOORFIELD HOUSE SURGERY — All Prescriptions & Medications — Page 2
Practice Code: B86658 | LEEDS, LS25 1AN
Showing results 51-100 of 619
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Gabapentin | 1,031 | 132.4K | £5.8K | +3.2% ▲ |
| Candesartan cilexetil | 1,027 | 44.4K | £2.0K | -13.4% ▼ |
| Naproxen | 973 | 44.4K | £1.9K | -1.4% vs avg |
| Edoxaban | 965 | 26.8K | £44.7K | +37.7% ▲ |
| Sitagliptin | 865 | 28.1K | £2.0K | +121.8% ▲ |
| Spironolactone | 844 | 20.6K | £2.6K | +56.5% ▲ |
| Other emollient preparations | 834 | 468.3K | £5.9K | +38.9% ▲ |
| Doxycycline hyclate | 826 | 10.6K | £1.0K | +61.1% ▲ |
| Finasteride | 820 | 30.9K | £1.1K | +25.2% ▲ |
| Morphine sulfate | 802 | 156.4K | £5.1K | +22.3% ▲ |
| Buprenorphine | 790 | 7,001 | £17.8K | +115.7% ▲ |
| Glucose blood testing reagents | 756 | 72.3K | £9.4K | -4.2% ▼ |
| Hydroxocobalamin | 751 | 982 | £2.1K | +56.1% ▲ |
| Digoxin | 749 | 15.8K | £1.2K | +97.9% ▲ |
| Tramadol hydrochloride | 744 | 69.5K | £4.1K | +3.8% ▲ |
| Famotidine | 738 | 31.5K | £17.0K | +51.3% ▲ |
| Rivaroxaban | 734 | 23.3K | £15.8K | +20.0% ▲ |
| Ferrous sulfate | 729 | 29.8K | £998 | +41.8% ▲ |
| Solifenacin | 728 | 20.9K | £1.3K | +52.6% ▲ |
| Progesterone | 714 | 56.0K | £10.8K | +70.6% ▲ |
| Levetiracetam | 699 | 58.3K | £14.3K | +52.7% ▲ |
| Docusate sodium | 693 | 39.2K | £2.9K | +86.9% ▲ |
| Hydrocortisone | 693 | 15.7K | £3.1K | +54.5% ▲ |
| Cetirizine hydrochloride | 686 | 40.3K | £1.7K | +37.3% ▲ |
| Flucloxacillin sodium | 686 | 31.1K | £1.7K | +52.6% ▲ |
| Desogestrel | 680 | 93.1K | £3.2K | +71.5% ▲ |
| Fluticasone furoate/vilanterol | 671 | 941 | £21.1K | +333.4% ▲ |
| 669 | 1,652 | £57.7K | +22.7% ▲ | |
| Alendronic acid | 662 | 3,324 | £866 | -11.7% ▼ |
| Carbocisteine | 658 | 72.5K | £3.0K | +23.2% ▲ |
| Felodipine | 647 | 24.6K | £3.9K | +9.0% ▲ |
| Isosorbide mononitrate | 644 | 20.1K | £3.5K | -2.6% ▼ |
| Sildenafil (Erectile Dysfunction) | 632 | 5,258 | £734 | +25.4% ▲ |
| Duloxetine hydrochloride | 631 | 21.7K | £1.7K | -0.7% vs avg |
| Venlafaxine | 623 | 32.0K | £5.6K | -26.3% ▼ |
| Gliclazide | 619 | 48.2K | £1.2K | -27.2% ▼ |
| Lercanidipine hydrochloride | 613 | 20.1K | £2.2K | -0.8% vs avg |
| Umeclidinium bromide/vilanterol | 588 | 724 | £22.4K | +201.5% ▲ |
| Nitrofurantoin | 585 | 7,442 | £4.4K | +22.6% ▲ |
| 579 | 71.5K | £2.8K | +22.0% ▲ | |
| Ferrous fumarate | 567 | 42.8K | £1.5K | -21.8% ▼ |
| Diltiazem hydrochloride | 558 | 21.4K | £3.6K | +81.7% ▲ |
| Thiamine hydrochloride | 556 | 32.4K | £847 | +5.5% ▲ |
| Budesonide | 548 | 710 | £15.3K | +1.1% vs avg |
| Latanoprost | 539 | 8,668 | £3.2K | +11.0% ▲ |
| Lamotrigine | 528 | 29.2K | £3.4K | -10.6% ▼ |
| Methotrexate | 521 | 18.6K | £1.2K | +60.1% ▲ |
| Memantine hydrochloride | 514 | 12.8K | £1.4K | +55.6% ▲ |
| 492 | 542 | £24.0K | +58.4% ▲ | |
| Mirabegron | 490 | 14.2K | £13.1K | +22.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.